Roche's fat-burning drug shows promise for diabetes

12/14/2011 | Bloomberg

Roche Holding's experimental fat-burning drug helped lower blood glucose levels for 30 days and induce a 10% weight reduction in mice with diabetes, a study in Science Translational Medicine revealed. The drug also helped activate calorie-burning brown fats, increase energy spending and decrease liver fat, researchers said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC